1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals

HAZZAN M. Daclizumab versus thymoglobulin in renal transplant recipients with a high
immunological risk: a prospective French-Belgian randomized trial.
119. GHISDAL L, LEBRANCHU Y, ALAMARTINE E, LE MEUR Y, TOUCHARD G,
NOËL C, ESSIG M, MERVILLE P, AZARCHOUCH Z, ABRAMOWICZ M,
ABRAMOWICZ D.
A missense mutation in proteasome B5 subunit is significantly associated with acute
rejection in non-immunized renal transplant patients.
Belgian Transplantation Society, Brussels, March 2011
120. BRACONNIER P, DELMARMOL V, BROEDERS N, KIANDA M, MASSART A,
LEMY A, GHISDAL L, LEMOINE A, MADHOUN P, RACAPÉ J, ABRAMOWICZ
D, WISSING KM. Combined introduction of anti-IL2 receptor antibodies,
mycophenolic acid and tracrolimus: effect on malignancies in a single centre
retrospective cohort study of 929 renal transplant recipients.
Belgian Transplantation Society, Brussels, March 2011
121. LEMY A, ANDRIEN M, LIONET A, LABALETTE M, NOEL C, HIESSE C,
DELAHOUSSE M, SUBERBIELLE C, DEMEYER M, LATINNE D, MOURAD M,
RACAPÉ J, WISSING KM, TOUNGOUZ M, ABRAMOWICZ D.
Impact of post-transplant MICA antibodies on long-term graft outcomes: a multicenter
analysis of 788 renal transplant patients.
Belgian Transplantation Society, Brussels, March 2011
122. Ghisdal L, Coppieters W, Lebranchu Y, Alamartine E, Le Meur Y, Touchard
G, Glowacki F, Essig M, Merville P, Ajarchouh Z, Dinic M, Massart A, Georges M,
Abramowicz M, Abramowicz D. Genome-wide association study identifies 13 loci
associated with acute T-cell rejection in caucasian renal transplant patients.
123. Kianda M, Wissing KM, Maddhoun P, Hougardy JM, Broeders N, Massart A,
Benahmed A, Vereerstraeten P, Hoang AD, Racapé J, Abramowicz D. Does loss
76